Compare Stocks: ECOR, ELMD, SENS, and TLSI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ECOR electroCore	$10.52 +3.0%	$7.73	$4.41 ▼ $10.95	$94.85M	0.92	95,636 shs	59,939 shs
ELMD Electromed	$39.45 -1.4%	$41.45	$19.15 ▼ $47.40	$326.65M	0.51	72,262 shs	157,115 shs
SENS Senseonics Holdings, Inc. Common Stock	$9.71 +10.1%	$6.11	$4.79 ▼ $11.58	$405.91M	1.01	752,539 shs	1.28 million shs
TLSI TriSalus Life Sciences	$5.27 +0.8%	$4.58	$2.20 ▼ $7.95	$324.50M	0.43	203,811 shs	98,694 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ECOR electroCore	0.00%	+5.52%	+65.41%	+57.72%	+101.92%
ELMD Electromed	0.00%	-4.29%	+3.33%	+3.22%	+101.17%
SENS Senseonics Holdings, Inc. Common Stock	0.00%	+24.33%	+99.38%	+53.15%	+970,999,900.00%
TLSI TriSalus Life Sciences	0.00%	0.00%	+23.42%	+61.66%	+2.93%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ECOR electroCore	$10.52 +3.0%	$7.73	$4.41 ▼ $10.95	$94.85M	0.92	95,636 shs	59,939 shs
ELMD Electromed	$39.45 -1.4%	$41.45	$19.15 ▼ $47.40	$326.65M	0.51	72,262 shs	157,115 shs
SENS Senseonics Holdings, Inc. Common Stock	$9.71 +10.1%	$6.11	$4.79 ▼ $11.58	$405.91M	1.01	752,539 shs	1.28 million shs
TLSI TriSalus Life Sciences	$5.27 +0.8%	$4.58	$2.20 ▼ $7.95	$324.50M	0.43	203,811 shs	98,694 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ECOR electroCore	0.00%	+5.52%	+65.41%	+57.72%	+101.92%
ELMD Electromed	0.00%	-4.29%	+3.33%	+3.22%	+101.17%
SENS Senseonics Holdings, Inc. Common Stock	0.00%	+24.33%	+99.38%	+53.15%	+970,999,900.00%
TLSI TriSalus Life Sciences	0.00%	0.00%	+23.42%	+61.66%	+2.93%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ECOR electroCore	2.00	Hold	$18.00	71.10% Upside
ELMD Electromed	2.75	Moderate Buy	$37.50	-4.94% Downside
SENS Senseonics Holdings, Inc. Common Stock	2.50	Moderate Buy	$17.20	77.14% Upside
TLSI TriSalus Life Sciences	2.25	Hold	$7.50	42.31% Upside

Current Analyst Ratings Breakdown

Latest ECOR, ELMD, SENS, and TLSI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/12/2026	SENS Senseonics Holdings, Inc. Common Stock	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/7/2026	TLSI TriSalus Life Sciences	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/28/2026	SENS Senseonics Holdings, Inc. Common Stock	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/15/2026	SENS Senseonics Holdings, Inc. Common Stock	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$20.00 ➝ $18.00
7/13/2026	ELMD Electromed	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
6/24/2026	ECOR electroCore	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
5/28/2026	SENS Senseonics Holdings, Inc. Common Stock	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)

(Data available from 8/23/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ECOR electroCore	$32.03M	2.96	N/A	N/A	($0.31) per share	-33.94
ELMD Electromed	$71.75M	4.55	$0.95 per share	41.36	$5.10 per share	7.74
SENS Senseonics Holdings, Inc. Common Stock	$35.26M	11.51	N/A	N/A	$2.16 per share	4.50
TLSI TriSalus Life Sciences	$45.15M	7.19	N/A	N/A	$0.11 per share	47.91

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ECOR electroCore	-$13.97M	-$1.66	N/A	N/A	N/A	-39.96%	-1,956.38%	-81.35%	11/4/2026 (Estimated)
ELMD Electromed	$5.15M	$1.17	52.60	N/A	N/A	11.34%	15.71%	13.37%	N/A
SENS Senseonics Holdings, Inc. Common Stock	-$69.11M	-$2.23	N/A	N/A	N/A	-225.09%	-165.80%	-80.14%	N/A
TLSI TriSalus Life Sciences	-$39.23M	-$1.30	N/A	N/A	N/A	-62.59%	N/A	-64.47%	N/A

Latest ECOR, ELMD, SENS, and TLSI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	ECOR electroCore	-$0.4218	-$0.33	+$0.0918	-$0.33	$9.49 million	$9.45 million
8/6/2026	Q2 2026	SENS Senseonics Holdings, Inc. Common Stock	-$0.55	-$0.63	-$0.08	-$0.63	N/A	$14.48 million
8/6/2026	Q2 2026	TLSI TriSalus Life Sciences	-$0.1550	-$0.16	-$0.0050	-$0.16	$10.27 million	$11.41 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ECOR electroCore	N/A	N/A	N/A	N/A	N/A
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
SENS Senseonics Holdings, Inc. Common Stock	N/A	N/A	N/A	N/A	N/A
TLSI TriSalus Life Sciences	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ECOR electroCore	N/A	1.21	1.00
ELMD Electromed	N/A	5.10	4.74
SENS Senseonics Holdings, Inc. Common Stock	0.62	6.74	6.40
TLSI TriSalus Life Sciences	5.05	5.35	4.97

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ECOR electroCore	26.74%
ELMD Electromed	40.82%
SENS Senseonics Holdings, Inc. Common Stock	12.36%
TLSI TriSalus Life Sciences	2.58%

Insider Ownership

Company	Insider Ownership
ECOR electroCore	7.80%
ELMD Electromed	10.50%
SENS Senseonics Holdings, Inc. Common Stock	4.70%
TLSI TriSalus Life Sciences	16.30%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ECOR electroCore	50	9.02 million	8.31 million	Not Optionable
ELMD Electromed	160	8.28 million	7.36 million	Optionable
SENS Senseonics Holdings, Inc. Common Stock	90	41.80 million	39.84 million	N/A
TLSI TriSalus Life Sciences	106	61.58 million	51.54 million	Not Optionable

ECOR, ELMD, SENS, and TLSI Headlines

Recent News About These Companies

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded at Wall Street Zen

August 23 at 1:06 AM | americanbankingnews.com

TriSalus Life Sciences (NASDAQ:TLSI) Upgraded to "Hold" at Wall Street Zen

August 23 at 1:05 AM | marketbeat.com

TriSalus Highlights Tumor-Treatment Expansion, FDA Catalyst at Growth Conference

August 17, 2026 | marketbeat.com

TriSalus Life Sciences (NASDAQ:TLSI) Cut to "Sell" at Wall Street Zen

August 15, 2026 | marketbeat.com

TriSalus Life Sciences (NASDAQ:TLSI) Posts Quarterly Earnings Results, Meets Expectations

August 7, 2026 | marketbeat.com

TriSalus Life Sciences Q2 Earnings Call Highlights

August 7, 2026 | marketbeat.com

TriSalus Life Sciences, Inc. (TLSI) Q2 2026 Earnings Call Transcript

August 6, 2026 | seekingalpha.com

TriSalus Life Sciences Reports Second Quarter 2026 Results

August 6, 2026 | businesswire.com

TriSalus Life Sciences (TLSI) to Post Earnings on Thursday

July 30, 2026 | marketbeat.com

TriSalus Life Sciences to Participate in the Canaccord Genuity 46th Annual Growth Conference

July 29, 2026 | businesswire.com

First Light Asset Management LLC Invests $20.27 Million in TriSalus Life Sciences, Inc. $TLSI

July 27, 2026 | marketbeat.com

TriSalus Life Sciences to Host Second Quarter 2026 Financial Results Conference Call

July 16, 2026 | businesswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 25, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 23, 2026 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 18, 2026 | prnewswire.com

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

June 17, 2026 | globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 16, 2026 | globenewswire.com

TLSI Investors Have Opportunity to Join TriSalus Life Sciences, Inc. Fraud Investigation with the Schall Law Firm

June 11, 2026 | prnewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of TriSalus Life Sciences Inc. - TLSI

June 11, 2026 | prnewswire.com

TriSalus Life Sciences to Host Virtual KOL Event on June 24 Featuring New Real-World Evidence for Pressure-Enabled Drug Delivery™ in Liver Cancer

June 10, 2026 | finance.yahoo.com

Why TriSalus Life Sciences, Inc.’s (TLSI) Stock Is Up 5.09%

June 10, 2026 | aaii.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ECOR, ELMD, SENS, and TLSI Company Descriptions

electroCore NASDAQ:ECOR

$10.52 +0.31 (+3.04%)

As of 08/21/2026 04:00 PM Eastern

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Electromed NYSE:ELMD

$39.45 -0.55 (-1.38%)

As of 08/21/2026 04:00 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

$9.71 +0.89 (+10.09%)

As of 08/21/2026 04:00 PM Eastern

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

TriSalus Life Sciences NASDAQ:TLSI

$5.27 +0.04 (+0.76%)

As of 08/21/2026 04:00 PM Eastern

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ECOR, ELMD, SENS, and TLSI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ECOR, ELMD, SENS, and TLSI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ECOR, ELMD, SENS, and TLSI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ECOR, ELMD, SENS, and TLSI Company Descriptions

electroCore NASDAQ:ECOR

Electromed NYSE:ELMD

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

TriSalus Life Sciences NASDAQ:TLSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ECOR, ELMD, SENS, and TLSI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ECOR, ELMD, SENS, and TLSI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ECOR, ELMD, SENS, and TLSI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ECOR, ELMD, SENS, and TLSI Company Descriptions

electroCore NASDAQ:ECOR

Electromed NYSE:ELMD

Senseonics Holdings, Inc. Common Stock NASDAQ:SENS

TriSalus Life Sciences NASDAQ:TLSI

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools